Gilead looks to make Remdesivir available globally

In India, people familiar with the development said the company is in discussions with Dr Reddy’s Laboratories, Cipla, Jubilant Lifesciences, and Strides Pharmaceuticals for granting them voluntary licences for manufacturing the drug.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2W4MeAq
via IFTTT